Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

16.25
+0.57003.64%
Pre-market: 15.81-0.4400-2.71%04:18 EDT
Volume:1.42M
Turnover:22.79M
Market Cap:2.36B
PE:-6.32
High:16.27
Open:15.71
Low:15.61
Close:15.68
Loading ...
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]